Finland vs Netherlands (Kingdom of the): Percentage of bloodstream infection due to methicillin-resistant
Finland
1.6%
in 2022
Netherlands (Kingdom of the)
2.3%
in 2022
Finland rank
49th
Netherlands (Kingdom of the) rank
47th
Percentage of bloodstream infection due to methicillin-resistant over time
- Finland
- Netherlands (Kingdom of the)
How they compare
Netherlands (Kingdom of the) currently reports 2.3% against 1.6% in Finland, a difference of 0.7%.
That makes Netherlands (Kingdom of the)'s figure about 1.4 times Finland's.
The two have swapped places 3 times across 6 shared years of data; in 2017 it was Finland ahead.
Finland ranks 49th and Netherlands (Kingdom of the) ranks 47th of 50 countries.
Across the 2 decades both report, Finland averaged higher in 1 and Netherlands (Kingdom of the) in 1.
Head to head by decade
| Decade | Finland | Netherlands (Kingdom of the) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.0% | 1.4% | 0.5% | Finland |
| 2020s | 1.7% | 1.8% | 0.1% | Netherlands (Kingdom of the) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Finland or Netherlands (Kingdom of the)?
- Netherlands (Kingdom of the), at 2.3% against 1.6% in Finland as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Finland and Netherlands (Kingdom of the)?
- 0.7%, with Netherlands (Kingdom of the) ahead.
- How many years of comparable data are there for Finland and Netherlands (Kingdom of the)?
- 6 years are reported by both, from 2017 to 2022.
- How do Finland and Netherlands (Kingdom of the) rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Finland ranks 49th and Netherlands (Kingdom of the) ranks 47th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.